• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> Recombinant GFAP Antibody / C-Terminal [Discontinued, view alternative antibodies]

Recombinant GFAP Antibody / C-Terminal [Discontinued, view alternative antibodies] [clone RM282] (R20299)

  Catalog No Formulation Size Price (USD)  
Image R20299-0.1ML Antibody in PBS with 50% glycerol, 1% BSA and 0.09% sodium azide 100 ul 369
Western blot testing of mouse brain lysate with recombinant GFAP antibody at 1:1000. Predicted molecular weight ~50 kDa.
IHC testing of FFPE human brain tissue with recombinant GFAP antibody at 1:200.
Availability Discontinued
Species Reactivity Human, Mouse
Format Purified
Clonality Recombinant Rabbit Monoclonal
Isotype Rabbit IgG
Clone Name RM282
Purity Protein A purified from animal origin-free supernatant
UniProt P14136
Gene ID 2670
Localization Cytoplasmic
Applications Immunohistochemistry : 1:100-1:200 dilution
Western blot : 1:1000-1:2000 dilution
Limitations This recombinant GFAP antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

This recombinant GFAP antibody reacts to the C-terminal region of human and mouse Glial Fibrillary Acidic Protein.

Application Notes

The stated application concentrations are suggested starting points. Titration of the recombinant GFAP antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Immunogen

A peptide corresponding to the C-terminus of human GFAP was used as the immunogen for this recombinant GFAP antibody.

Storage

Store the recombinant GFAP antibody at -20oC (with glycerol) or aliquot and store at -20oC (without glycerol).

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.